I missed this post from you earlier. I first posted on PCYC and ibrutinib on this board way back in early 2009 here: #msg-36998377 . I followed up with a post here where I saw some potential in the stock and made reference to what might lead me to invest: #msg-38344930 . Here are some of your initial comments (I believe) on the stock and BTK with some caution noted in 2009 in response to my post where I noted I was "keeping an eye on PCYC" (LOL makes it even more painful knowing I never invested) due to the small market cap: #msg-42852870. There are plenty more posts in 2009 and 2010 if you just search but I don't want to pull up any more as it's too painful. LOL In the end, I think it was a combo of prior management issues, fact that PCYC in-licensed ibrutinib from Celera (as opposed to having developed it in-house), and fact that shares took a nice jump after the initial PoC data that led to me never buying any shares.
I give you absolute credit here. I was pretty skeptical of your comments, given that PCYC already had made a bit of a run and I thought some expectations were built in at that point but, in the grand scheme of things, it wasn't that much of a run up until that point given where we are now. I'm hoping I do better this time around listening to you on FGEN.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.